Department of HPB Surgery and Liver Transplant, Royal Free London, London, United Kingdom.
Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.
Eur J Surg Oncol. 2020 May;46(5):740-746. doi: 10.1016/j.ejso.2020.01.028. Epub 2020 Jan 23.
Intrahepatic cholangiocarcinoma (iCCA) is the second most common hepatic malignancy and its incidence has been shown to increase significantly during the past decades. Complete surgical resection is currently acknowledged as the only curative treatment option able to provide adequate long-term outcomes. We herein review technical, functional and oncologic limitations for resectability, discuss current surgical aspects as well as highlight the fields in which future research and practice should focus on in order to ameliorate long-term outcomes in patients with iCCA.
肝内胆管细胞癌(iCCA)是第二常见的肝脏恶性肿瘤,其发病率在过去几十年中显著增加。目前,完全手术切除被认为是唯一能够提供充分长期疗效的治愈性治疗选择。本文回顾了 iCCA 可切除性的技术、功能和肿瘤学限制,讨论了当前的手术方面,并强调了未来研究和实践应关注的领域,以改善 iCCA 患者的长期疗效。